Report

The global computational biology market was valued at USD 5.25 Billion in 2024 driven by increasing investments in computational biology research and the rising interdisciplinary collaborations across the globe. The market is further expected to grow at a CAGR of 22.50% in the forecast period of 2025-2034 to attain a value of over USD 39.95 Billion by 2034.

Global Computational Biology Market Overview

Computational biology is defined as a field of science that involves the collection, storage, organization, and analysis of a large amount of biological, medical, and health-related data with the help of computers, databases, applied mathematics, statistics, and others. It involves the development and application of mathematical modelling, computational simulation techniques, and data-analytical methods to study biological systems.

The global computational biology market is driven by its growing demand in various end-use sectors, including academics and research studies. The computational approaches help enhance the management of a large volume of data during clinical trials and allow for the efficient utilization of biological data to develop algorithms. The rapid development of molecular biology and genetic engineering tools has been contributing to the market growth significantly. The growing application of computational biology in various commercial and third-party services for carrying out drug discovery processes is likely to boost the market share in the forecast period. Other factors that influence the market growth include advancements in bioinformatics tools, innovations in cloud computing, and increased grants and funding programs to support computational biology research.

Global Computational Biology Market Growth Drivers

Regulatory Support for Advanced Computational Methods to Affect the Market Landscape Significantly

In August 2023, biosimulation company Certara's division Simcyp Group received two new grants from the United States Food and Drug Administration (FDA) with the aim of expanding its innovative predictive models for drug virtual bioequivalence (VBE) studies and creating a formulation toolbox for topically applied drugs. This collaboration with the FDA will facilitate the development of model-informed approaches and is likely to ensure faster and more cost-effective development of novel drugs as well as complex generics. The rising regulatory support towards the integration of advanced computational methods in drug safety and efficacy evaluations is anticipated to bolster market growth in the coming years.

Increased Investment to Meet Rising Computational Biology Market Demand

There is a growing recognition of the importance and potential of computational biology, which is attracting significant investments from institutional investors, private donors, and venture capitalists. For instance, in November 2023, Carnegie Mellon University's Computational Biology Department received an investment of USD 25 million from the university's trustees. The funding was intended to be used in establishing an endowment, supporting the program's strategic priorities and infrastructure development. Such financial backing in the field of computational biology is poised to promote innovation and the development of new technologies, which will ultimately impact market growth.

Global Computational Biology Market Trends

The market is witnessing several trends and developments to improve the current global scenario. Some of the notable trends are as follows:

Integration of Artificial Intelligence and Machine Learning

One of the major market trends is the use of artificial intelligence (AI) and machine learning (ML) in computational biology which is enhancing the analysis of complex biological data. The rising development of AI-driven predictive models to simulate drug interactions and predict patient responses to therapies is expected to expedite the market growth.

Growth of Personalized Medicine

Computational tools are accelerating the development of targeted therapies and personalized treatment plans, which are likely to improve patient outcomes and augment market demand. Moreover, the increasing availability of genomic data and advancements in bioinformatics are facilitating the growth of personalized medicine.

Increased Collaboration and Interdisciplinary Research

The computational biology market share is influenced by the increased collaborative efforts across multiple disciplines, including biology, computer science, mathematics, and engineering. There is a growing trend of interdisciplinary research and collaboration among academic institutions, research organizations, and key market players which is anticipated to propel the development and commercialization of new computational tools.

Adoption of High-Performance Computing (HPC) and Cloud Computing

The increasing adoption of high-performance computing (HPC) and cloud computing in computational biology is driving advances in genomics, drug discovery, and systems biology and is poised to impact the market dynamics. These technologies allow efficient handling of the growing volume of biological data and perform complex simulations.

Global Computational Biology Market Segmentation

Market Breakup by Services

- On-Premises
- Cloud-Based

Market Breakup by Application

- Genomics and Genetics
- Drug Discovery and Development
- Others

Market Breakup by End User

- Academics
- Industry
- Commercial

Market Breakup by Region

- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa

Global Computational Biology Market Share

Market Segmentation Based on Application Areas is Anticipated to Witness Substantial Growth

The market breakup by application includes genomics and genetics, and drug discovery and development, among others. The genomics and genetics segment employs computational biology in the analysis and interpretation of genetic and genomic data. Computational tools are increasingly utilized in genome sequencing and analysis, genetic variation and mutation analysis, comparative genomics, and others. This segment benefits significantly by leveraging advanced computational biology techniques in research studies for facilitating an enhanced understanding of genetic disorders and the development of genetic tests. The drug discovery and development segment is also poised to witness substantial growth, owing to the growing demand for computer simulations in drug design, virtual screening to identify potential drug candidates, and the process of discovering new drugs and therapies.

Global Computational Biology Market Analysis by Region

Based on the region, the market covers North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. In North America, the market holds a considerable share and is driven by the growing investments directed at the development of efficient design and modeling-related computational tools to assess the complexity of biological systems. Over the forecast period, the rising government funding towards academic and biological research studies in countries like the United States and Canada is likely to propel the market growth. The market will further be aided by the rising penetration of advanced digital solutions and high-performance computation tools, coupled with the increasing research and development across the region.

Leading Players in the Global Computational Biology Market

The key features of the market report comprise funding and investment analysis and strategic initiatives by the key players. The major companies in the market are as follows:

Chemical Computing Group

The software company based in Canada, is a key player in the market and is known for its drug discovery software platform MOE (Molecular Operating Environment) which integrates modeling and simulations, visualization, and methodology development.

Dassault Systemes S.E.

This French multinational software corporation, specializing in the development of software for 3D product design and simulation, is a prominent player in the market. One of its popular products is the BIOVIA Pipeline Pilot which allows researchers to automate complex data analysis processes.

Certara, Inc.

Certara offers a wide range of services in model-based drug development, regulatory science, and clinical pharmacology and significantly contributes to the computational biology market growth. It boasts a robust portfolio including leading PK/PD modeling and simulation software Phoenix�.

Instem plc

Instem plc, a global provider of software solutions and services, offers a broad range of solutions supporting both preclinical and clinical research. The company is known for its ALPHADAS software solution, a clinical trial management system (CTMS) designed for early-phase clinical trials.

Other key players in the market include Compugen, Genedata, YOKOGAWA DENKI KABUSHIKI KAISHA, STRAND LIFE SCIENCES PRIVATE LIMITED, Schrodinger, Inc., and SimulationPlus.